Delivery Order SPE2DB22D1106-SPE2DB24FEVP3

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,055.52 firm-fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML syringes, a specialty medication. The contract has a period of performance through November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the pharmaceutical product AJOVY 225MG/1.5ML 1S. The $2,462.88 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is a civilian agency under the Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,532.43 for the supply of the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,055.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of AJOVY 225 MG/1.5 ML SYRINGE 1.5ML, with a period of performance ending on October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The contract has a ceiling value of $1,036.20 and an ultimate completion date of April 22, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed-price basis without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $1,163.98 fixed-price delivery order is for the pharmaceutical product AJOVY 225 MG/1.5 ML SYRINGE 1.5ML. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of Ajovy 225 mg/1.5 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,618.14 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.36 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a completion date of July 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,883.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of AJOVY 225 MG/1.5 ML SYRINGE 1.5ML, a pharmaceutical product, with an ultimate completion date of April 18, 2024. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,231.44 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a completion date of September 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEVP3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,055.52 for the supply of AJOVY 225 MG/1.5 ML SYRINGE 1.5ML. The contract is being awarded by the Defense Logistics Agency (DLA), a defense agency, and is not set aside for any specific business designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/4/24, 9:30 AM